RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

被引：0
|
作者：
Chunyue Wang
Zhenlong Zhang
Yulan Sun
Song Wang
Mengmeng Wu
Qiuxiang Ou
Yang Xu
Zhiming Chen
Yang Shao
Hong Liu
Peifeng Hou
机构：
[1] Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine
[2] Shengli Clinical Medical College of Fujian Medical University,Department of Thoracic Surgery
[3] Fujian Provincial Hospital,Department of Internal Medicine Division
[4] Shandong Cancer Hospital Affiliated to Shandong First Medical University,Department of Radiation Oncology
[5] Geneseeq Research Institute,Department of Medical Oncology
[6] Nanjing Geneseeq Technology Inc.,undefined
[7] Affiliated Hospital of Nantong University,undefined
[8] Qilu Hospital of Shandong University,undefined
[9] Fujian Medical University Union Hospital,undefined
来源：
Journal of Translational Medicine | / 20卷
关键词：
rearrangement; NSCLC; EGFR-TKI; Noncanonical ; fusion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer
    Wang, Chunyue
    Zhang, Zhenlong
    Sun, Yulan
    Wang, Song
    Wu, Mengmeng
    Ou, Qiuxiang
    Xu, Yang
    Chen, Zhiming
    Shao, Yang
    Liu, Hong
    Hou, Peifeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [2] RET Fusions as Primary Oncogenic Drivers and Secondary Acquired Resistance to EGFR TKI in a Large Cohort of Non-Small-Cell Lung Cancers
    Wang, C.
    Zhang, Z.
    Wu, M.
    Yin, J.
    Wu, X.
    Shao, Y.
    Hou, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S489 - S490
  • [3] Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
    Wang, Jun
    Wang, Baocheng
    Chu, Huili
    Yao, Yunfeng
    ONCOTARGETS AND THERAPY, 2016, 9 : 3711 - 3726
  • [4] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yu Yao
    Huaping Yang
    Bo Zhu
    Song Wang
    Jiaohui Pang
    Xiaoying Wu
    Yang Xu
    Junli Zhang
    Jinfeng Zhang
    Qiuxiang Ou
    Hui Tian
    Zheng Zhao
    Respiratory Research, 24
  • [5] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
    Yao, Yu
    Yang, Huaping
    Zhu, Bo
    Wang, Song
    Pang, Jiaohui
    Wu, Xiaoying
    Xu, Yang
    Zhang, Junli
    Zhang, Jinfeng
    Ou, Qiuxiang
    Tian, Hui
    Zhao, Zheng
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [6] RET Inhibitors in Non-Small-Cell Lung Cancer
    Cascetta, Priscilla
    Sforza, Vincenzo
    Manzo, Anna
    Carillio, Guido
    Palumbo, Giuliano
    Esposito, Giovanna
    Montanino, Agnese
    Costanzo, Raffaele
    Sandomenico, Claudia
    De Cecio, Rossella
    Piccirillo, Maria Carmela
    La Manna, Carmine
    Totaro, Giuseppe
    Muto, Paolo
    Picone, Carmine
    Bianco, Roberto
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2021, 13 (17)
  • [7] Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors
    Xu, H.
    Shu, Y.
    Jian, H.
    Shen, J.
    Xiang, J.
    Li, H.
    Li, B.
    Zhang, T.
    Zhang, L.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S562 - S563
  • [8] Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
    Zucali, P. A.
    Ruiz, M. G.
    Giovannetti, E.
    Destro, A.
    Varella-Garcia, M.
    Floor, K.
    Ceresoli, G. L.
    Rodriguez, J. A.
    Garassino, I.
    Comoglio, P.
    Roncalli, M.
    Santoro, A.
    Giaccone, G.
    ANNALS OF ONCOLOGY, 2008, 19 (09) : 1605 - 1612
  • [9] Pyrimidine derivatives as EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: A comprehensive review
    Kizhakkedath Ratheesh, Anandu
    Pottankottu Jayan, Ajay
    Presanna, Aneesh Thankappan
    Nirmala, Saiprabha Vijayakumar
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (04) : 599 - 621
  • [10] Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives
    Kim, Toe-You
    Han, Soe-Won
    Bang, Yung-Jue
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (06) : 821 - 836
12345